cel healthcare fund iii first closing, managing size over 3 billion rmb
china everbright limited (cel, stock code: 165.hk) announced that its third healthcare fund (cel healthcare fund iii) has completed its first closing and raised more than rmb800 million. total target size of cel healthcare fund iii is rmb1.5 billion. including previous two cel healthcare funds, total healthcare fund under cel’s management exceeds rmb 3 billion.
healthcare is always a favorable industry of cel. its first healthcare fund was established in 2012 and covers healthcare service, medical instrument and equipment, innovative medicine, diagnostic reagents, and other areas of healthcare industry. leveraging rich resources and professionalism of investment team of cel, cel healthcare funds successfully invested in many outstanding enterprises, including bgi (300676 sz), betta pharmaceutical (300558 sz), china traditional chinese medicine holdings co. ltd (00570 hk), amcare, lifetech (01302 hk), etc.
cel healthcare fund iii will fully leverage past experience and strategic value of cel to drive the connection of global high-end medical technology, medical equipment, biological pharmaceutical, medical services to chinese market; and integration between global advanced technology & product and leading chinese companies.
leverage their rich industrial operation, capital markets and equity investment experience and deep understanding on healthcare market in china, cel healthcare team will assist their portfolio companies in all aspects, including strategy, management, marketing, technology, merger & acquisition and finance to grow them into leading companies in their sectors.
established in hong kong in 1997, cel is a leading cross-border investment and asset management institution in china. it manages a number of private funds, venture capital funds, industrial funds, mezzanine funds, fofs, fixed income funds and hedge funds. total fund under cel’s management exceeds hk$140 billion. cel has over 200 investment professionals with strong investment and fund management capabilities. after 21 years of development, cel has accumulated rich experience and strong capability in cross-border asset management.
